-
-
-
-
-
-
-
Lyra Therapeutics (LYRA) says ENLIGHTEN 1 trial did not meet its primary endpoint
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Announces FDA Acceptance of Application for Subcutaneous Nivolumab
-
-
-
-
-
-
-
Gossamer Bio Inc. (GOSS) Announces Publication of TORREY Phase 2 Results
-
-
-
-
-
-
-
Palatin Technologies (PTN) Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity
-
-
-
-
-
-
-
Aileron Therapeutics (ALRN) Reports Positive Data from Cohort 1 of the Phase 1b Trial of LTI-03
-
-
-
-
-
-
-
ARS Pharmaceuticals (SPRY) Submits Response for neffy Marketing Authorization Application to EMA’s CHMP, Enters License Agreement with CSL Seqirus
-
-
-
-
-
-
-
Virpax Pharmaceuticals (VRPX) Announces Results of Maximum Tolerated Dose Study for Probudur
-
66,983 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.